MedPath

A clinical trial to study the effects of mumps-measles-rubella vaccine in improving patients with multiple warts in ski

Phase 3
Conditions
Health Condition 1: null- Multiple Cutaneous Warts
Registration Number
CTRI/2017/10/010021
Lead Sponsor
Dr Prof Shyam Sundar Chaudhary
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i.Male or female patients with multiple warts who are candidate for treatment between 18 and 65 years of age (both inclusive).

ii.Patients who give their informed consent.

Exclusion Criteria

i.Pregnant and lactating women.

ii.Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid use etc.).

iii.Any other systemic disease (eg. liver or kidney disorder).

iv.Presence of mucosal wart(s).

v.Presence of ulcerated or inflamed wart(s).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
number of visible warts on the skinTimepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
the number of patients showing complete resolution of wartsTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath